Pretherapeutic First-In-Human Targeting Trial Of Anti-Hk2 Antibody H11b6: A Potential Molecular Vector For Alpha-Particle Radioimmunotherapy.

Michael J. Morris,Joseph A. O' Donoghue,Dushen Chetty, Steven Max,Danielle Wanik,Mike Russell, Tenzin Nyima,Anjali Narayan Avadhani, Chaitanya R Divgi,Neeta Pandit-Taskar

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 0|浏览3

暂无评分

摘要

122Background: Radioligand therapy for metastatic castration resistant prostate cancer (mCRPC) has focused to date on targeting prostate specific membrane antigen, an approach associated with saliv...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要